Isn’t Korab Zuka at Gilead now and wasn’t he a VP at the Patient Access Network Foundation (PAN), which is now under investigation with the OIG for running a co-payment assistance/scheme with Pfizer? And, Pfizer just settled on this for $25 M. I find it interesting that the same person responsible for this is not part of Gikead’s Public Affairs team. Sad, really.
I hope so. Then I can dump this dog of a stock with at least a small profit. The glory days of Gilead are far in the past. The only thing they have proven in the past couple of years is they can't seem to make good decisions anymore.